Drug Type Toxin |
Synonyms α4/7-conotoxin (CTx) LvID |
Target |
Action antagonists |
Mechanism α7 receptor antagonists(Neuronal acetylcholine receptor protein alpha-7 subunit antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | China | 10 Apr 2025 | |
| Alzheimer Disease | Preclinical | China | 10 Apr 2025 | |
| Alzheimer Disease | Preclinical | China | 10 Apr 2025 | |
| Atherosclerosis | Preclinical | China | 10 Apr 2025 | |
| Atherosclerosis | Preclinical | China | 10 Apr 2025 | |
| Atherosclerosis | Preclinical | China | 10 Apr 2025 | |
| Lung Cancer | Preclinical | China | 10 Apr 2025 | |
| Lung Cancer | Preclinical | China | 10 Apr 2025 | |
| Lung Cancer | Preclinical | China | 10 Apr 2025 | |
| Myasthenia Gravis | Preclinical | China | 10 Apr 2025 |






